Phase 1b Study of Dato-DXd in Combination with Pembrolizumab with or without Platinum Chemotherapy in Advanced or Metastatic Non-Small Cell Lung Cancer

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508003-20-00

Acronym

DS1062-A-U102

Enrollment

Registered

2024-06-21

Start date

2021-09-27

Completion date

Unknown

Last updated

2025-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026